{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:05:40Z","timestamp":1791335140929,"version":"4.3.1"},"reference-count":57,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_rir-2025-0004_s_101\">\n                  <jats:title>Background and Objective<\/jats:title>\n                  <jats:p>Rheumatoid arthritis (RA) is a chronic autoimmune condition characterized by joint pain and inflammation. RA involves elevated expression of nuclear factor kappa B (NF-\u03baB), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-\u03b1), which drive synovial inflammation and joint destruction primarily through the STAT-3 signalling pathway. Nitazoxanide (NTZ) has been shown in previous studies to inhibit the signalling of STAT-3.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_rir-2025-0004_s_102\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This study evaluated the anti-arthritic effects of NTZ in a rat model of complete Freund\u2019s adjuvant (CFA) induced arthritis. NTZ was administered orally at doses of 400, 200, and 100 mg\/kg over 28 days. Various parameters, including changes in paw swelling, body weight, arthritic index, haematological measurements, levels of inflammatory cytokines, and histopathological analysis, were monitored.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_rir-2025-0004_s_103\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>NTZ treatment significantly improved body weight and reduced paw swelling, edema, and the arthritic index in CFA-induced arthritic rats. The treatment also decreased white blood cell counts while increasing red blood cell and haemoglobin levels. NTZ effectively modulated inflammatory cytokine levels and showed improvement in the histopathology of the ankle joints.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_rir-2025-0004_s_104\">\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>NTZ exhibited significant anti-arthritic activity through the inhibition of the STAT-3 and NF-\u03baB pathways, emphasizing its potential as a therapeutic option for rheumatoid arthritis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/rir-2025-0004","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T07:52:04Z","timestamp":1743666724000},"page":"29-41","source":"Crossref","is-referenced-by-count":12,"title":["Nitazoxanide alleviates CFA-induced rheumatoid arthritis in Wistar rats by modulating the STAT-3 and NF-\u03baB pathways"],"prefix":"10.1515","volume":"6","author":[{"given":"Pradyuman","family":"Prajapati","sequence":"first","affiliation":[{"name":"Department of Pharmacology, SVKM\u2019s Dr Bhanuben Nanavati College of Pharmacy , Vile Parle (W) , Mumbai , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Doshi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, SVKM\u2019s Dr Bhanuben Nanavati College of Pharmacy , Vile Parle (W) , Mumbai , India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"2025040307331986801_j_rir-2025-0004_ref_001","doi-asserted-by":"crossref","unstructured":"Wei T, Liu Y, Li M. Anti-inflammatory and Anti-arthritic Activity of Rosmarinic acid Isolated from Rosmarinus officinalis in an Experimental Model of Arthritis. Ind J Pharm Edu Res. 2021;55:507\u2013516.","DOI":"10.5530\/ijper.55.2.89"},{"key":"2025040307331986801_j_rir-2025-0004_ref_002","doi-asserted-by":"crossref","unstructured":"Kumar A, Dhaliwal N, Dhaliwal J, et al. Astaxanthin attenuates oxidative stress and inflammatory responses in complete Freund-adjuvant-induced arthritis in rats. Pharmacol Rep. 2020;72:104\u2013114.","DOI":"10.1007\/s43440-019-00022-z"},{"key":"2025040307331986801_j_rir-2025-0004_ref_003","doi-asserted-by":"crossref","unstructured":"Cai Y, Zhang J, Liang J, et al. The Burden of Rheumatoid Arthritis: Findings from the 2019 Global Burden of Diseases Study and Forecasts for 2030 by Bayesian Age-Period-Cohort Analysis. J Clin Med. 2023;12:1291.","DOI":"10.3390\/jcm12041291"},{"key":"2025040307331986801_j_rir-2025-0004_ref_004","doi-asserted-by":"crossref","unstructured":"Weng W, Wang F, He X, et al. Protective effect of Coryno-line on the CFA induced Rheumatoid arthritis via attenuation of oxidative and inflammatory mediators. Mol Cell Biochem. 2021;476:831\u2013839.","DOI":"10.1007\/s11010-020-03948-8"},{"key":"2025040307331986801_j_rir-2025-0004_ref_005","doi-asserted-by":"crossref","unstructured":"Kumar V, Anwar F, Verma A, et al. Therapeutic effect of umbelliferon-\u03b1-D-glucopyranosyl-(2(I)\u21921(II))-\u03b1-D-glucopyranoside on adjuvant-induced arthritic rats. J Food Sci Technol. 2015;52:3402\u20133411.","DOI":"10.1007\/s13197-014-1403-x"},{"key":"2025040307331986801_j_rir-2025-0004_ref_006","doi-asserted-by":"crossref","unstructured":"Kumar V, Bhatt PC, Rahman M, et al. Melastoma malabathri-cum Linn attenuates complete freund\u2019s adjuvant-induced chronic inflammation in Wistar rats via inflammation response. BMC Complement Altern Med. 2016;16:510.","DOI":"10.1186\/s12906-016-1470-9"},{"key":"2025040307331986801_j_rir-2025-0004_ref_007","doi-asserted-by":"crossref","unstructured":"Tian Z, Zhang H, Shang C. Farrerol ameliorate adjuvant-in-duced ankle injury via alteration of PPAR-\u03b3 signal pathway. J Food Biochem. 2021;45:e13585.","DOI":"10.1111\/jfbc.13585"},{"key":"2025040307331986801_j_rir-2025-0004_ref_008","doi-asserted-by":"crossref","unstructured":"Anchi P, Swamy V, Godugu C. Nimbolide exerts protective effects in complete Freund\u2019s adjuvant induced inflammatory arthritis via abrogation of STAT-3\/NF-\u03baB\/Notch-1 signaling. Life Sci. 2021;266:118911.","DOI":"10.1016\/j.lfs.2020.118911"},{"key":"2025040307331986801_j_rir-2025-0004_ref_009","doi-asserted-by":"crossref","unstructured":"Bais S, Abrol N, Prashar Y, et al. Modulatory effect of standardised amentoflavone isolated from Juniperus communis L. agianst Freund\u2019s adjuvant induced arthritis in rats (histopathological and X Ray anaysis). Biomed Pharmacother. 2017;86:381\u2013392.","DOI":"10.1016\/j.biopha.2016.12.027"},{"key":"2025040307331986801_j_rir-2025-0004_ref_010","doi-asserted-by":"crossref","unstructured":"Cui P, Qu F, Sreeharsha N, et al. Antiarthritic effect of chitosan nanoparticle loaded with embelin against adjuvant-induced arthritis in Wistar rats. IUBMB Life. 2020;72:1054\u20131064.","DOI":"10.1002\/iub.2248"},{"key":"2025040307331986801_j_rir-2025-0004_ref_011","doi-asserted-by":"crossref","unstructured":"Ouyang L, Dan Y, Shao Z, et al. Effect of umbelliferone on ad-juvant-induced arthritis in rats by MAPK\/NF-\u03baB pathway. Drug Des Devel Ther. 2019;13:1163\u20131170.","DOI":"10.2147\/DDDT.S190155"},{"key":"2025040307331986801_j_rir-2025-0004_ref_012","doi-asserted-by":"crossref","unstructured":"Ogata A, Kato Y, Higa S, et al. IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review. Mod Rheumatol. 2019;29:258\u2013267.","DOI":"10.1080\/14397595.2018.1546357"},{"key":"2025040307331986801_j_rir-2025-0004_ref_013","doi-asserted-by":"crossref","unstructured":"Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9:798\u2013809.","DOI":"10.1038\/nrc2734"},{"key":"2025040307331986801_j_rir-2025-0004_ref_014","doi-asserted-by":"crossref","unstructured":"Cheng WX, Huang H, Chen JH, et al. Genistein inhibits an-giogenesis developed during rheumatoid arthritis through the IL-6\/JAK2\/STAT3\/VEGF signalling pathway. J Orthop Translat. 2019;22:92\u2013100.","DOI":"10.1016\/j.jot.2019.07.007"},{"key":"2025040307331986801_j_rir-2025-0004_ref_015","doi-asserted-by":"crossref","unstructured":"Tian ZC, Wang JQ, Ge H. Apatinib ameliorates doxorubicininduced migration and cancer stemness of osteosarcoma cells by inhibiting Sox2 via STAT3 signalling. J Orthop Translat. 2019;22:132\u2013141.","DOI":"10.1016\/j.jot.2019.07.003"},{"key":"2025040307331986801_j_rir-2025-0004_ref_016","doi-asserted-by":"crossref","unstructured":"He X, Zhu B, Xie W, et al. Amelioration of imiquimod-induced psoriasis-like dermatitis in mice by DSW therapy inspired hydro-gel. Bioact Mater. 2020;6:299\u2013311.","DOI":"10.1016\/j.bioactmat.2020.08.007"},{"key":"2025040307331986801_j_rir-2025-0004_ref_017","doi-asserted-by":"crossref","unstructured":"Kaul A, Gordon C, Crow MK, et al. Systemic lupus erythemato-sus. Nat Rev Dis Primers. 2016 Jun;2:16039.","DOI":"10.1038\/nrdp.2016.39"},{"key":"2025040307331986801_j_rir-2025-0004_ref_018","doi-asserted-by":"crossref","unstructured":"O\u2019Shea JJ, Holland SM, Staudt LM. JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med. 2013;368:161\u2013170.","DOI":"10.1056\/NEJMra1202117"},{"key":"2025040307331986801_j_rir-2025-0004_ref_019","doi-asserted-by":"crossref","unstructured":"White CA Jr. Nitazoxanide: a new broad spectrum antiparasitic agent. Expert Rev Anti Infect Ther. 2004;2:43\u201349.","DOI":"10.1586\/14787210.2.1.43"},{"key":"2025040307331986801_j_rir-2025-0004_ref_020","doi-asserted-by":"crossref","unstructured":"Di Santo N, Ehrisman J. A functional perspective of nitazoxanide as a potential anticancer drug. Mutat Res. 2014;768:16\u201321.","DOI":"10.1016\/j.mrfmmm.2014.05.005"},{"key":"2025040307331986801_j_rir-2025-0004_ref_021","doi-asserted-by":"crossref","unstructured":"Rossignol JF. Nitazoxanide: a first-in-class broad-spectrum antiviral agent. Antiviral Res. 2014;110:94\u2013103.","DOI":"10.1016\/j.antiviral.2014.07.014"},{"key":"2025040307331986801_j_rir-2025-0004_ref_022","doi-asserted-by":"crossref","unstructured":"Shakya A, Bhat HR, Ghosh SK. Update on Nitazoxanide: A Multifunctional Chemotherapeutic Agent. Curr Drug Discov Technol. 2018;15:201\u2013213.","DOI":"10.2174\/1570163814666170727130003"},{"key":"2025040307331986801_j_rir-2025-0004_ref_023","doi-asserted-by":"crossref","unstructured":"L\u00fc Z, Li X, Li K, et al. Structure-Activity Study of Nitazoxanide Derivatives as Novel STAT3 Pathway Inhibitors. ACS Med Chem Lett. 2021;12:696\u2013703.","DOI":"10.1021\/acsmedchemlett.0c00544"},{"key":"2025040307331986801_j_rir-2025-0004_ref_024","doi-asserted-by":"crossref","unstructured":"Hu X, Li J, Fu M, et al. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther. 2021;6:402.","DOI":"10.1038\/s41392-021-00791-1"},{"key":"2025040307331986801_j_rir-2025-0004_ref_025","doi-asserted-by":"crossref","unstructured":"Mori T, Miyamoto T, Yoshida H, et al. IL-1\u03b2 and TNF\u03b1-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cyto-kines and RANKL expression in inflammatory arthritis. Int Immunol. 2011;23:701\u2013712.","DOI":"10.1093\/intimm\/dxr077"},{"key":"2025040307331986801_j_rir-2025-0004_ref_026","doi-asserted-by":"crossref","unstructured":"Li CH, L\u00fc ZR, Zhao ZD, et al. Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis. Front Pharmacol. 2021;12:781640.","DOI":"10.3389\/fphar.2021.781640"},{"key":"2025040307331986801_j_rir-2025-0004_ref_027","doi-asserted-by":"crossref","unstructured":"McLornan DP, Pope JE, Gotlib J, et al. Current and future status of JAK inhibitors. Lancet. 2021;398:803\u2013816.","DOI":"10.1016\/S0140-6736(21)00438-4"},{"key":"2025040307331986801_j_rir-2025-0004_ref_028","doi-asserted-by":"crossref","unstructured":"Murphy JR, Friedmann JC. Pre-clinical toxicology of ni-tazoxanide--a new antiparasitic compound. J Appl Toxicol. 1985;5:49\u201352.","DOI":"10.1002\/jat.2550050202"},{"key":"2025040307331986801_j_rir-2025-0004_ref_029","doi-asserted-by":"crossref","unstructured":"Dar E, Mobashar A, Shabbir A, et al. Mechanistic Evaluation of Antiarthritic Effects of Citronellol in CFA-Induced Arthritic Rats. ACS Omega. 2023;8:44955\u201344963.","DOI":"10.1021\/acsomega.3c06374"},{"key":"2025040307331986801_j_rir-2025-0004_ref_030","doi-asserted-by":"crossref","unstructured":"Halil Sezgin Semis, Cihan Gur, Mustafa Ileriturk, et al. Investigation of the anti-inflammatory effects of caffeic acid phenethyl ester in a model of \u03bb-Carrageenan-induced paw edema in rats. Hum Exp Toxicol. 2021;40:S721\u2013S738.","DOI":"10.1177\/09603271211054436"},{"key":"2025040307331986801_j_rir-2025-0004_ref_031","doi-asserted-by":"crossref","unstructured":"Choudhary N, Gupta R, Bhatt LK. Anti-rheumatic activity of Phenethyl isothiocyanate via inhibition of histone deacetylase-1. Chem Biol Interact. 2020;324:109095.","DOI":"10.1016\/j.cbi.2020.109095"},{"key":"2025040307331986801_j_rir-2025-0004_ref_032","doi-asserted-by":"crossref","unstructured":"Vogel H. Antiarthrotic and Immunomodulatory Activity. In: Vogel, H.G. (eds) Drug Discovery and Evaluation. Springer, Berlin, Heidelberg, 2007.","DOI":"10.1007\/978-3-540-70995-4_10"},{"key":"2025040307331986801_j_rir-2025-0004_ref_033","doi-asserted-by":"crossref","unstructured":"Nakano K, Whitaker JW, Boyle DL, et al. DNA methylome signature in rheumatoid arthritis. Ann Rheum Dis. 2013;72:110\u2013117.","DOI":"10.1136\/annrheumdis-2012-201526"},{"key":"2025040307331986801_j_rir-2025-0004_ref_034","doi-asserted-by":"crossref","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"2025040307331986801_j_rir-2025-0004_ref_035","doi-asserted-by":"crossref","unstructured":"Mostafizar M, Cortes-P\u00e9rez C, Snow W, et al. Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-\u03baB) in the Central Nervous System. Cells. 2021;10:1335.","DOI":"10.3390\/cells10061335"},{"key":"2025040307331986801_j_rir-2025-0004_ref_036","doi-asserted-by":"crossref","unstructured":"Kumar R, Gupta YK, Singh S, et al. Picrorhiza kurroa Inhibits Experimental Arthritis Through Inhibition of Pro-inflammatory Cyto-kines, Angiogenesis and MMPs. Phytother Res. 2016;30:112\u2013119.","DOI":"10.1002\/ptr.5509"},{"key":"2025040307331986801_j_rir-2025-0004_ref_037","doi-asserted-by":"crossref","unstructured":"Obiri DD, Osafo N, Ayande PG, et al. Xylopia aethiopica (An-nonaceae) fruit extract suppresses Freund\u2019s adjuvant-in-duced arthritis in Sprague-Dawley rats. J Ethnopharmacol. 2014;152:522\u2013531.","DOI":"10.1016\/j.jep.2014.01.035"},{"key":"2025040307331986801_j_rir-2025-0004_ref_038","doi-asserted-by":"crossref","unstructured":"Evans CH, Robbins PD. Pathways to gene therapy in rheumatoid arthritis. Curr Opin Rheumatol. 1996;8:230\u2013234.","DOI":"10.1097\/00002281-199605000-00011"},{"key":"2025040307331986801_j_rir-2025-0004_ref_039","doi-asserted-by":"crossref","unstructured":"Chernajovsky Y, Annenkov A, Herman C, et al. Gene therapy for rheumatoid arthritis. Theoretical considerations. Drugs Aging. 1998;12:29\u201341.","DOI":"10.2165\/00002512-199812010-00004"},{"key":"2025040307331986801_j_rir-2025-0004_ref_040","unstructured":"Kaur A, Nain P, Nain J. Herbal plants used in the treatment of rheumatoid arthritis: A review. Int J Pharm Pharm Sci. 2012;4:44\u201357."},{"key":"2025040307331986801_j_rir-2025-0004_ref_041","doi-asserted-by":"crossref","unstructured":"Buch MH. Defining refractory rheumatoid arthritis. Ann Rheum Dis. 2018;77:966\u2013969.","DOI":"10.1136\/annrheumdis-2017-212862"},{"key":"2025040307331986801_j_rir-2025-0004_ref_042","doi-asserted-by":"crossref","unstructured":"Philips RL, Wang Y, Cheon H, et al. The JAK-STAT pathway at 30: Much learned, much more to do. Cell. 2022;185:3857\u20133876.","DOI":"10.1016\/j.cell.2022.09.023"},{"key":"2025040307331986801_j_rir-2025-0004_ref_043","doi-asserted-by":"crossref","unstructured":"Liu JY, Hou YL, Cao R, et al. Protodioscin ameliorates oxidative stress, inflammation and histology outcome in Complete Freund\u2019s adjuvant induced arthritis rats. Apoptosis. 2017;22:1454\u20131460.","DOI":"10.1007\/s10495-017-1420-0"},{"key":"2025040307331986801_j_rir-2025-0004_ref_044","doi-asserted-by":"crossref","unstructured":"Kaithwas G, Majumdar DK. Therapeutic effect of Linum usitatis-simum (flaxseed\/linseed) fixed oil on acute and chronic arthritic models in albino rats. Inflammopharmacology. 2010;18:127\u2013136.","DOI":"10.1007\/s10787-010-0033-9"},{"key":"2025040307331986801_j_rir-2025-0004_ref_045","doi-asserted-by":"crossref","unstructured":"Scherer HU, H\u00e4upl T, Burmester GR. The etiology of rheumatoid arthritis. J Autoimmun. 2020;110:102400.","DOI":"10.1016\/j.jaut.2019.102400"},{"key":"2025040307331986801_j_rir-2025-0004_ref_046","doi-asserted-by":"crossref","unstructured":"Wahba MG, Messiha BA, Abo-Saif AA. Protective effects of fe-nofibrate and resveratrol in an aggressive model of rheumatoid arthritis in rats. Pharm Biol. 2016;54:1705\u20131715.","DOI":"10.3109\/13880209.2015.1125931"},{"key":"2025040307331986801_j_rir-2025-0004_ref_047","doi-asserted-by":"crossref","unstructured":"Bhalekar MR, Upadhaya PG, Nalawade SD, et al. Anti-rheumatic activity of chloroquine-SLN gel on wistar rats using complete freund\u2019s adjuvant (CFA) model. Indian J Rheumatol. 2015;10:58\u201364","DOI":"10.1016\/j.injr.2015.03.008"},{"key":"2025040307331986801_j_rir-2025-0004_ref_048","doi-asserted-by":"crossref","unstructured":"Hasan H, Ismail H, El-Orfali Y, et al. Therapeutic benefits of Indole-3-Carbinol in adjuvant-induced arthritis and its protective effect against methotrexate induced-hepatic toxicity. BMC Complement Altern Med. 2018;18:337.","DOI":"10.1186\/s12906-018-2408-1"},{"key":"2025040307331986801_j_rir-2025-0004_ref_049","doi-asserted-by":"crossref","unstructured":"Patil KR, Patil CR, Jadhav RB, et al. Anti-Arthritic Activity of Bartogenic Acid Isolated from Fruits of Barringtonia racemosa Roxb. (Lecythidaceae). Evid Based Complement Alternat Med. 2011;2011:785245.","DOI":"10.1093\/ecam\/nep148"},{"key":"2025040307331986801_j_rir-2025-0004_ref_050","unstructured":"Sun W, Suo QF, Wang WF, et al. Effects of Curcumol on car-rageenan Induced Oedema and Complete Freund\u2019s AdjuvantInduced Arthritis in Rats. Lat Am J Pharm. 2014;33:266\u2013272."},{"key":"2025040307331986801_j_rir-2025-0004_ref_051","doi-asserted-by":"crossref","unstructured":"Gaafar AGA, Messiha BAS, Abdelkafy AML. Nicorandil and theophylline can protect experimental rats against complete Freund\u2019s adjuvant-induced rheumatoid arthritis through modulation of JAK\/STAT\/RANKL signaling pathway. Eur J Pharmacol. 2018;822:177\u2013185.","DOI":"10.1016\/j.ejphar.2018.01.009"},{"key":"2025040307331986801_j_rir-2025-0004_ref_052","doi-asserted-by":"crossref","unstructured":"Zheng K, Zhao Z, Lin N, et al. Protective Effect of Pinitol Against Inflammatory Mediators of Rheumatoid Arthritis via Inhibition of Protein Tyrosine Phosphatase Non-Receptor Type 22 (PTPN22). Med Sci Monit. 2017;23:1923\u20131932.","DOI":"10.12659\/MSM.903357"},{"key":"2025040307331986801_j_rir-2025-0004_ref_053","doi-asserted-by":"crossref","unstructured":"Li C, Wang F, Han Y, et al. Nitazoxanide reduces inflammation and bone erosion in mice with collagen-induced arthritis via inhibiting the JAK2\/STAT3 and NF-\u03baB pathways in fibroblast-like synoviocytes. Biomed Pharmacother. 2024;171:116195.","DOI":"10.1016\/j.biopha.2024.116195"},{"key":"2025040307331986801_j_rir-2025-0004_ref_054","doi-asserted-by":"crossref","unstructured":"Alfons Billiau, Patrick Matthys. Collagen-induced arthritis and related animal models: how much of their pathogenesis is auto-immune, how much is auto-inflammatory? Cytokine Growth Factor Rev. 2011;22:339\u2013344.","DOI":"10.1016\/j.cytogfr.2011.11.003"},{"key":"2025040307331986801_j_rir-2025-0004_ref_055","doi-asserted-by":"crossref","unstructured":"Hoisnard L, Lebrun-Vignes B, Maury S, et al. Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database. Sci Rep. 2022;12:7140.","DOI":"10.1038\/s41598-022-10777-w"},{"key":"2025040307331986801_j_rir-2025-0004_ref_056","doi-asserted-by":"crossref","unstructured":"Onda K, Honma T, Masuyama K. Methotrexate-related adverse events and impact of concomitant treatment with folic acid and tumor necrosis factor-alpha inhibitors: An assessment using the FDA adverse event reporting system. Front Pharmacol. 2023;14:1030832.","DOI":"10.3389\/fphar.2023.1030832"},{"key":"2025040307331986801_j_rir-2025-0004_ref_057","doi-asserted-by":"crossref","unstructured":"Rossignol JF, Bardin MC, Fulgencio J, et al. A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19. EClinicalMedicine. 2022;45:101310.","DOI":"10.1016\/j.eclinm.2022.101310"}],"container-title":["Rheumatology and Immunology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/rir-2025-0004\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/rir-2025-0004\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T07:52:50Z","timestamp":1743666770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/rir-2025-0004\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,4,2]]},"published-print":{"date-parts":[[2025,4,2]]}},"alternative-id":["10.1515\/rir-2025-0004"],"URL":"https:\/\/doi.org\/10.1515\/rir-2025-0004","relation":{},"ISSN":["2719-4523"],"issn-type":[{"value":"2719-4523","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]}}}